[Malignant exophtalmos in hyperthyroidism with a hypothyroid crisis].
METHODS
We present the case of a 56-year-old male with a malignant exophthalmos in the context of Graves' disease. He suffered a significant worsening coincident with a hypothyroid crisis, and various therapeutic approaches were required for reduction of the proptosis.


CONCLUSIONS
When managing this condition, both the severity of the exophthalmos and the activity of the thyroid must be considered when choosing which of the different therapeutic approaches should be employed.
Campos-Pavón
J
J
Servicio de Oftalmología, Hospital 12 de Octubre, Universidad Complutense, Madrid, España.
Mencía-Gutiérrez
E
E
Gutiérrez-Díaz
E
E
D000208:Acute Disease; D000273:Adipose Tissue / Q000601:surgery; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D003131:Combined Modality Therapy; D019299:Decompression, Surgical; D004359:Drug Therapy, Combination; D005094:Exophthalmos / Q000188:drug therapy / Q000209:etiology* / Q000532:radiotherapy / Q000601:surgery; D015353:Eye Enucleation; D005901:Glaucoma / Q000209:etiology / Q000601:surgery; D049970:Graves Ophthalmopathy / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009915:Orbit / Q000528:radiation effects
D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D002257:Carbonic Anhydrase Inhibitors; D008775:Methylprednisolone